СПИСОК ЛИТЕРАТУРЫ

1. Айламазян, Э.К. Акушерство. Национальное руководство / Э.К. Айламазян, В.И. Кулаков, В.Е. Радзинский, Г.М. Савельеава. – ГЭОТАР – Медиа.- 2009.

– 1200 с.

2. Аржанова, О.Р.

3. Бекман, Ч Акушерство и гинекология / Ч. Бекман, Ф. Линг, Б. Баржански и др.

- М.: Медицинская литература. – 2004. – 584 с.

4. Елютин, Д.В. Эндогенная интоксикация у женщин с гестозом, перенесших кесарево сечение / Д.В. Елютин, Д.В. Садчиков, Н.Ю. Шанина и др. // Акуш Гинек. – 2002. - №1. – С. 20 – 23.

5. Кобчикова, А.В. Исследование уровня гомоцистеина и показателей наследственной тромбофилии у беременных с гестозом / А.В. Кобчикова, А.В. Арутюнян, М.С. Зайнуллина и др. // Журнал акуш женск болезней. – 2012. - №61(2). – С. 21 – 26.

6. Кошелева, Н.Г. Система гемостаза и иммуноморфологичесике состояния плаценты при антифрсфолипидных антителах в плазме / Н.Г. Кошелева, О.Н. Зубжицкая, О.Н. Аржанова и др. // Журнал акуш и женск болезней. – 2004. - №53. – С. 22-26.

7. Куликов, А.В. Клинико-морфологические особенности HELLP-синдрома /

А.В. Куликов, С.В. Спирин, С.И. Блауман // Анестезия реаниматол. – 2010. -

№6. – С. 87-91.

8. Макаров, И.О. Течение беременности и родов у пациенток с ожирением / И.О. Макаров, Е.И. Боровкова, М.Ю. Байрамова // Акуш Гинек Репрод. – 2011. - №1. – С. 22 – 28.

9. Макаров, О.В. Артериальная гипертензия у беременных. Только ли гестоз? / О.В. Макаров, Н.Н. Николаев, Е.В. Волкова. - М.:ГЭОТАР-Медиа, 2006. – 174с.

10. Макаров, О.В. Значение аутоантител в патогенезе преэклампсии/

О.В. Макаров, Ю.А. Богатырев, Н.А. Осипова // Акуш гинек. – 2012. - №4(1).

– С. 16 – 21.

11. Макаров, О.В. Перспективы диагностики и прогнозирования преэклампсии / О.В.

12. Манухин, И.Б. Оптимизация комплексного лечения беременных с гестозом и фетоплацентарной недостаточностью / И.Б. Манухин, Е.В. Маркова, Р.И. Стрюк // Российский вестник акушера-гинеколога. – 2012. - №2. – С. 81- 84.

13. Михайлова, В.А. Эндотелиальные клетки и их микрочастицы в периферической крови при физиологической беременности и при гестозе / В.А. Михайлова, О.М. Овчинникова, С.А. Сельков и др. // Журнал акуш женск болезней. – 2012. - №61(1). – С. 47- 54.

14. Норвитц, Э.Р. Наглядное акушерство и гинекология / Э.Р. Норвитц, Д.О. Шардж. – М.: ГЭОТАР-МЕД, 2003. - 144 с.

15. Павлов, О.В. Иммунология репродукции: старые догмы и новые представления / О.В. Павлов, С.А. Сельков // Журнал акуш женск болезн. – 2004.-№1.–С.89-97.

16. Погорелов, В.М. Тромбоцитарные параметры при нормально протекающей беременности и гестозе / В.М. Погорелов, Г.И. Козинец, И.О. Макаров и др. // Акуш гинек репродукция. – 2012. - №3. – С. 28 – 33.

17. Приоритетные национальные проекты «Здоровье». – М.: ГЭОТАР-Медиа, 2006. – 59 с.

18. Радзинский, В.Е. Акушерская агрессия / В.Е. Радзинский. – М.: Изд-во журнала Status Praesens, 2011.– 688 с.

19. Радзинский, В.Е. Современные технологии фитотерапии в акушерстве и гинекологии / В.Е. Радзинский // Журнал акуш женск болезней. – 2003. - №1.

– С. 83-88.

20. Румянцев, П.О. Статистические методы анализа в клинической практике /

П.О. Румянцев, В.А. Саенко, У.В. Румянцева, С.Ю. Чекин // Проблемы

эндокринологии. – М.: Медиа Сфера, 2009. – Том 55.- №5. – С. 48-55.

21. Серов, В.Н. Профилактика осложнений беременности высокого риска /

В.Н. Серов // Эффективная фармакотерапия. – 2011. - №2. – С. 82-83.

22. Серов, В.Н. Эклампсия / В.Н. Серов, С.А. Маркин, А.Ю. Лубнин. – М.: МИА, 2002. – 464 с.

23. Сидорова, И.С. Новые данные о генезе гестоза и оценке степени его тяжести / И.С. Сидорова, А.Г. Габибов, Н.А. Никитина // Акуш Гинек.

24. Сидорова, И.С. Эндотелиальная дисфункция в развитии гестоза /

И.С. Сидорова, И.Л. Галинова // Вопросы гинек акуш перинат. – 2006. -

№5(1). – С. 75-81.

25. Степанова, Р.Н. Беременность и аберрации иммунитета / Р.Н. Степанова. –

М.: Спутник Плюс, 2013. - 135с.

26. Степанова, Р.Н. Заболевания шейки матки у беременных женщин: материнские и перинатальные исходы / Р.Н. Степанова, Е.В. Коломеец // Росс Мед Вестник. – 2010. - №15(4). – С. 38 – 45.

27. Степанова, Р.Н. Невынашивание беременности в Таджикистане: причины, факторы риска, прогноз, профилактика: дис. ... д-ра.мед.наук: 14.00.01 / Степанова Римма Николаевна. - М.,1994. - 226с.

28. Степанова, Р.Н. Профилактика субоптимальных материнских и перинатальных исходов беременности высокого риска ОПГ-гестоза / Р.Н. Степанова // Росс Bестник акуш гинекол. – 2001. - №1. – С. 43-45.

29. Степанова, Р.Н. Преэклампсия: эпидемиология, прогноз, профилактика /

Р.Н. Степанова. – LAP, - 2013. – 248 с.

30. Сулейманова, Н.С. Роль антигенов гистосовместимости при физиологической и патологической беременности / Н.С. Сулейманова, Н.В. Зарецкая, С.А. Тимофеев и др. // Акуш Гинек. – 2001. - №5. – С. 3-4.

31. Тарасова, Л.П. Материнская заболеваемость и смертность в Орловской области: причины, факторы риска, прогноз, профилактика: автореф. дис. ... канд. мед. наук: 14.00.01 / Тарасова Людмила Петровна. – М., 2008. – 26 с.

32. Токова, З.З. Гестоз и материнская летальность / З.З. Токова, О.Г. Фролова //

Росс Bестник акуш-гинек. – 2005. - №5(3). – С. 52-55.

33. Тютюнник, В.Л. Диагностика и лечение плацентарной недостаточности у беременных с варикозным расширением вен малого таза / В.Л. Тютюнник, Д.М. Магометханова // РМЖ. – 2007. - №15(17). – С. 1289-1293.

34. Хофмейр, Д.Ю. Кокрановское руководство: беременность и роды.

Профилактика гипертензивных рассторойств / Д.Ю. Хофмейр, Д.П. Нейлсон, З. Алфиревич и др.; по ред. Г.Сухих. – М.: Логосфера, 2010. – С. 55-69.

35.

36. Шеманаева, Т.В. Прогностическая значимость молекул адгезии клеток сосудов в оценке степени тяжести гестоза / Т.Б. Шеманаева, И.С. Сидорова, О.И. Гурина // Акуш Гинек. – 2008. - №2. – С. 16-22.

37. Aardema, M.W. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses / M.W. Aardema, H. Oosterhof, A. Timmer et al. // Placenta. – 2001. – N.22. – P. 405-411.

38. Abumaree, M.N. Trophoblast debris modulates the expression of immune proteins in macrophages: a rty to maternal tolerance of the fetal allograft / M.N. Abumaree,

L.W. Chamley, M. Badri et al. // J Reprod Immunol. – 2012. – Vol.94, N.2. – P. 131 – 141.

39. Agarwal, A. Role of oxidative stress in female reproduction / A. Agarwal,

S. Gupta, R. Sharma // Reprod Biol Endocrinol. – 2005. – N.3. – P. 28.

40. Akolekar, R. Maternal plasma inhibin A at 11 – 13 weeks of gestation in hypertensive disorders of pregnancy / R. Akolekar, R. Minekawa, A. Veduta et al.

// Prenat Diagn. – 2009. – N.29. – P. 753 – 760.

41. Akolekar, R. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11- 13 weeks of gestation in preeclampsia /

R. Akolekar, J.Cruz, J-M. Foidart et al. // Prenatal Diagnosis. – 2010. – N.30. - P.

191-197.

42. Akolekar, R. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11 – 13 weeks /

R. Akolekar, Syagelaki, R. Sarquis et al. // Prenat Diagn. – 2011. – N.31. – P. 66 – 74.

43. Aksornphusitaphong, A. Risk factors of early and late onset pre-eclampsia /

A. Aksornphusitaphong V. Phupong // J. Obstet. Gynaecol. Res. – 2013. - Vol. 39,

- N.3. – P.

44. Al-Balushi, M.S. Fluctuation in the levels of immunoglobulin M and immunoglobulin G antibodies for cardiolipin and β₂-Glycoprotein among healthy pregnant women / M.S. Al-Balushi, S.S. Hasson, E.A. Said et al. // Sultan Qaboos Univ Med J. – 2014. – Vol.14(4). – P. e478–e485.

45. Anastasakis, E. Association between abnormal uterine artery Doppler flow velocimetry, risk of preeclampsia, and indices of arterial structure and function /

E. Anastasakis , K. Paraskevas, N. Papanfoniou et al. // Angiology. – 2008. – Vol.59, N4. – P. 493-499.

46. Anna, R.D. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction / R.D. Anna, G. Baviera,

F. Corrado et al. // Acta Obstet Gynecol Scand. – 2004. – Vol.83, N.2. – P. 155- 158.

47. Askie, L.M. Antiplatelet agents for prevention of preeclampsia / L.M. Askie,

L. Duley, D. Henderson-Smart et al. // Lancet.–2007.–Vol.369, N.9575.– P.1791– 1798.

48. Bahado-Singh, R.O. First-trimester metabolomic detection of late-onset preeclampsia / R.O. Bahado-Singh, R. Akolekar, R. Mandal et al. // AJOG. – 2013.

– Vol.208, - N.1. – P. 58.e1–58.e7.

49. Barton, J.R. Prediction and prevention of recurrent preeclampsia // J.R. Barton,

B.M. Sibai // Obstet Gynecol. – 2008. – N.112. – P. 359–372.

50. Baschat, A.A. Prediction of preeclampsia utilizing the first trimester screening examination // A.A. Baschat, L.S. Magder, L.E. Doyle et al. // American Journal of

Obstetrics & Gynecology. – 2014. – Vol.211, - N.5. – P. 514.e1–514.e7.

51. Baumann, M.U. Serum markers for predicting pre-eclampsia / M.U. Baumann,

N.A Bersinger, D.V. Surbek // Mol aspects Med. – 2007. – Vol.28, N.2. – P. 227- 244.

52. Berlac, J.F. Obstetrical and neonatal outcomes in women following gastric bypass: a Danish national cohort study / J.F. Berlac, C.W. Skovlund, O. Lidegaad et al. // AOGS. – 2014. - Vol. 93, - N.5. – P. 454-462.

53.

R.A. Odegard // Acta Obstet Gynecol Scand. – 2004. – Vol.83, N.1. – P. 37-45.

54. Bezerra Maia e Holanda Moura, S. Prevention of preeclampsia / S. Bezerra Maia e Holanda Moura, L Marques Lopes, P. Murthi et al. // Journal of Pregnancy. - 2012. - Vol.2012. - Article ID 435090, 9 pages.

55. Bigelow, C.A. Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsia / C.A.Bigelow, G.A. Pereira, A. Warmsley et al.

// Am J Obstet Gynecol. – 2014. – Vol.210, N.4. – P. 338.e1-338.e8.

56. Black, M. Outcomes of pregnancy in women using illegal drugs and in women who smoke cigarettes // M. Black, S. Bnattacharya, T. Faivley, D.M. Campbell, A.S. Shetty // AOGS. – 2013. - Vol. 92, - N.1. – P. 47-52.

57. Bramham, K. Adverse maternal and perinatal outcomes in women with previous preeclampsia / K. Bramham, A. Briley, P. Seed et al. // Am J Obstet Gynecol. – 2011. – Vol.204, N.6. – P. 512e1-e9.

58. Branch, D.W. Antiphospholipid syndrome: obstetric diagnosis, management and controversies / D.W. Branch, M.A. Khamashta // Obstet Gynecol. – 2003. – N.101.

– P. 1333-1344.

59. Briceffio-Perez, C. Prediction and prevention ofr preeclampsia / C. Briceffio- Perez, L. Briceffio-Sanabria, P. Vigil-DeGracia // Hypertens Pregnancy. – 2009. – Vol.28, N.2. – P. 138 – 155.

60. Buchimschi, C.S. Fractional excretion of angiogenic factors in women with several preeclampsia / C.S. Buchimschi, L. Magloire, E. Funai // Obstet Gynecol. – 2006.

– N.107. – P. 1103-1113.

61. Buchimschi, C.S. Urinary angiogenic factors cluster hypertensive disorders and identific women with severe preeclampsia / C.S. Buchimschi, E.R. Norwitz,

E. Funai et al. // Am J Obstet Gynecol.- 2005. – Vol.192, N.3. – P. 734-741.

62. Bujold, E. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis / E. Bujold, F.V.Morency, S.Roberge et al. // J Obstet Gynecol Can. – 2009. – Vol.31, N.9. – P. 818-826.

63. Bujold, E. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy / E. Bujold, S. Roberge, Y. Lacasse et al. // Obstet Gynecol. – 2010. – Vol.116, N.2, part1. – P. 402-414.

64. Cakovic, M. Fractional excretion of tumor necrosis Factor- α women with severe preeclampsia / M. Cakovic, C. Buhimschi, G. Zhao et al. // Obstet Gynecol. 2008. - N.112,1. – P. 93-100.

65. Canini, S. Assosiation between birth weigth and first-trimester free β-human chorionic gonadotropin and pregnancy-associated plasma protein A / S. Canini,

F. Prefumo, D. Pastorino et al. // Fertil Steril. – 2008. – Vol.89, N.1. – P. 174 – 178.

66. Canniggia, I. Oxygen and placental development during the first trimester: implications for the pathophysiology of preeclampsia / I. Canniggia, J. Witer,

S.J. Lye, M. Post // Placenta. – 2000. – N.21, supplA. - S25-S30.

67. Carty, D.M. Novel biomarkers for predicting preeclampsia / D.M. Carty, Ch. Delles, A.F. Dominiczak // Trends Cardiovasc Med. – 2008. – N.18. – P. 186 – 194.

68. Castellino, G. Uterine artery doppler in predicting pregnancy outcome in women with connective tissue disorders / G. Castellino, R. Capucci, M. Govoni et al. // Rheumatology. – 2006. – Vol.45, N.9. – P. 1174-1175.

69. Chaiworapongsa, T. Pre-eclampsia part 1: current understanding of its pathophysiology / T. Chaiworapongsa, P. Chaemsaithong, L. Yeo et al. // Nature Reviews Nephrology. – 2014. – Vol.10. – P. 466–480.

70. Chaiworapongsa, T. Pre-eclampsia part 2: prediction, prevention and management

/ T. Chaiworapongsa, P. Chaemsaithong, S.J. Korzeniewski et al. // Nature Reviews Nephrology. – 2014. – Vol.10. – P. 531–540.

71. Chaiworopongsa, T. Evidence supporting a role for blocade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia /

T. Chaiworopongsa, R. Romero, J. Espinoza et al. // Am J Obstet Gynecol. – 2004.

– Vol.190, N.6. – P. 1541-1550.

72. Clark, E.A.S. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? E.A.S. Clark, R.M. Silver, D.W. Branch et al. // Current Rheumatology Reports. - 2007, - Vol.9, - N.3. – P. 219-225.

73. Cnattingius, S. The paradoxical effect of smoking in preeclamptic pregnancies /

S. Cnattingius, J. Mills, J. Yuen // Am J Obstet Gynecol. – 1997. – Vol.177, N.1. – P. 156-161.

74. Cnossen, J.S. Use of uterine artery Doppler ultrasonography to predict pre- eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis / J.S. Cnossen, R.K. Morris, G. Riet et al. // CMAJ. – 2008. – N.178.

– P. 701-711.

75. Coghill, S. Risk factors for eclampsia: a population-based study in Washington State, 1987 – 2007 / S. Coghill, S. Hansen, A.J. Littman // Fm J Obstet Gynecol. – 2011. – Vol.205, N.6. – P. 553e1 – 553e7.

76. Conde-Agudelo, A. Maternal morbidity and mortality associated with interpregnancy interval / A. Conde-Agudelo, J.M. Belizan // Br Med J– 2000.– N.321 – P.1255-1259.

77. Conde-Agudelo, A. Supplementation with vitamin C and vitamin E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcome / A. Conde-Agudelo, R. Romero, J. Kusanovic, S. Hassan // Am J Obstet Gynecol. -2011. – Vol.204, N.6. – P. 503e1-e12.

78. Conde-Agudelo, A. World health organization systematic review of screening tests for preeclampsia / A. Conde-Agudelo, J. Villar, M. Lindheimer // Obstet Gynecol.

– 2004. – Vol.104, N.6. – P. 1367-1391.

79. Coonrod, D.V. Ethnicity, acculturation and obstetric outcomes / D.V. Coonrod,

R.C. Bay, H. Balcazar // J Reprod Med. – 2004. – Vol.49, N.1. – P. 17-22.

80. Costa, S. Early screening for preeclampsia / S. Costa, P. Murthi, R. Keogh, N.Woodrow // Rev Bras Ginecol Obstet. – 2011.- Vol.33, N.11. – P. 367 – 375.

81. Crispi, F. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction /

F. Crispi, E. Llurba, C. Dominguez et al. // Ultrasound Obstet Gynecol. - 2008. – Vol. 31, - N.3. – P. 303–309.

82. Cuckle, H. Current controversies in prenatal diagnosis 4: pregnancy complications due to placental vascular disease (pre-eclampsia, FGR): are we ready for prevention / H. Cuckle, P. von Dadelszen, A. Ghidini // Prenatal Diagnosis. – 2013. – Vol.33, - N.1. – P. 17–20.

83. Cunningham, F.G. Williams Obstetrics, 22th ed NY-Toronto / F.G. Cunningham,

K.J. Leveno, S.L. Bloom et al. MC GRAW-Hill, 2005.

84. D'Antonio, F. Comparison of wavelet transform and time-domain analysis of second trimester uterine artery doppler waveforms in screening for pre-eclampsia /

F. D'Antonio, P. Hamilton, R.Pinnock et al. // Fetal Diagn Ther. – 2013. - Vol. 33, - N.3. – P. 189-193.

85. Dekker, G. Primary, secondary and tertuary prevention of pre-eclampsia / G. Dekker, B.Sibai // Lancet. – 2001. – N.357. – P. 209 – 215.

86. Dekker, G.A. Etiology and pathogenesis of preeclampsia: current concepts /

G.A. Dekker, B.M. Sibai // Am J Obstet Gynecol. – 1998. – N.179. – P. 1359- 1375.

87. Dreyfus, M. Antiphospholipid antibodies and preeclampsia: a case-control study /

M. Dreyfus, G.Hedelin, R. Kutnahorsky et al. // Obstetrics & Gynecology. – 2001.

- Vol. 97, - N. 1.

88. Duckitt, K. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies / K. Duckitt, D.Harrington // Br Med J– 2005.–N.330.– P.565–569.

89. Duley, L.J. Antiplatelet drugs for prevention of pre-eclampsia and its

consequences: systematic review / L.J. Duley, D. Henderson-Smart, M. Knight // Brit Med J. – 2001. – N.322. – P. 329-333.

90. Esplin, M.S. Paternal and maternal components of the predisposition to preeclampsia / M.S. Esplin, M.B. Fausett, A. Fraser et al. // N Engl J Med. – 2001.

– N.344. – P. 867-872.

91. Gernand, A.D. Maternal vitamin D status and Small-for-gestational-age offspring in women at high risk for preeclampsia / A.D. Gernand, H.N. Simhan, S. Caritis // Obstetrics & Gynecology. – 2014. – Vol.123, N.1. – P. 40-48.

92. Giguere, L. Combining biochemical and ultrasonographic markers in predicting preeclampsia / L. Giguere, M. Charland, E. Bujold et al. // Clinical Chemistry. – 2010. – Vol.56, N.3. – P. 361 – 374.

93. Goetzinger, K.R. Efficiency of first-trimester uterine artery doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein A, and maternal characteristics in the prediction of preeclampsia / K.R. Goetzinger, Y. Zhong,

A.G. Cahill et al. // J Ultrasound Med. – 2013. - Vol.32, - N.9. – P. 1593-1600.

94. Goetzinger, K.R. Predicting the risk of pre-eclampsia between 11 and 13 weeks gestation by combining maternal characteristics and serum analites, PAPP-A and free b-hCG / K.R. Goetzinger, A. Singla, S.Gerkovitcz // Prenat Diagn. – 2010. – VOL.30, N.12-13. – P. 1138 – 1142.

95. Goldenberg, R.L. Maternal mortality / R.L. Goldenberg, E.M.McClure // Am J Obstet Gynecol. – 2011. – N.205. – P. 293 – 295.

96. Gonen, R. Placental protein13 as early marker for pre-eclampsia / R. Gonen, R. Shahar, Y. Grimpel et al. // BJOG.- 2008. – N.115. – P. 1465 – 1472.

97. Grill, S. Potential markers of preeclampsia-review / S.Grill, C. Rusterholz,

R. Zanetti-Dallenbach et al. // Reprod Biol Endocrinol. – 2009. – N.7. – P. 70-93.

98. Grobman, W.A. Serum levels of activin A and inhibin A and the subsequent development of pre-eclampsia / W.A. Grobman, J. Eileen // Obstet Gynecol. – 2000. – Vol.96, N.3. – P. 390–394.

99. Gurgel Alves, J.A. First-trimester maternal ophthalmic artery Doppler analysis for prediction of pre-eclampsia / J.A. Gurgel Alves, P.C. Praciano de Sousa,

S. Bezerra Maia e Holanda Moura et al. // Ultrasound Obstet Gynecol. - 2014. – Vol.44, - N.4. – P. 411–418.

100. Hairong, Xu. Role of nutrition in the risk of preeclampsia / Xu. Hairong,

B. Shatenstein, Luo Zhong-Cheng et al. // Nutrition rev. – 2009. – Vol.67, N.11. – P. 639-657.

101. Hai-Tao, Yuan. Angiogenic factors in the pathogenesis of preeclampsia / Yuan.

Hai-Tao, D. Haig, A.Karumanchi // Cur Top Development Biol.–2005.–N.71.– P.297-312.

102. Hanisch, C.G. Adhesion molecules, activin and inhibin candidates for the biochemical prediction of hypertensive diseases in pregnancy? / C.G. Hanisch,

K.A. Pfeiffer, H. Schlebusch, J. Schmolling // Arch.Gynecol Obstet. – 2004. – Vol.270, N.2. – P. 110-115.

103. Hayashi, M. Elevation of serum macrophage colony-stimulating factor before the clinical manifestations of preeclampsia / M. Hayashi, T. Ohkura, N. Inaba // Am J Obstet Gynecol. – 2003. – N.189. – P. 1356-1360.

104. Heyborne, K.D. Preeclampsia prevention: lessons from the low-dose aspirin therapy trials / K.D. Heyborne // Am J Obstet Gynecol. – 2000. – Vol.183, N.3. – P. 523-528.

105. Hofmeyr, G.J. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems / G.J. Hofmeyr, T.A. Lawrie,

A.N. Atallach, L.Duley. - Cochrane Database Syst Rev. - 2010(8), CD001059.

106. Hofmeyr, G.J. Dietary calcium supplementation for prevention of pre-eclampsia and related problems / G.J. Hofmeyr, L. Duley, A.Atallah // BJOG. – 2007. – N.114. – P. 933 – 943.

107. Hogberg, V. The effect of smoking and hypertensive disorders on abruptio placentae / V.Hogberg, S. Rasmussen, L.M. Irgens // Acta Obstet Gynecol Scand.

– 2007. – Vol.86, N.3. – P. 304-309.

108. Hogg, B. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia and intrauterine growth restriction / B.Hogg, Т. Tamura, K. Johnston et al. // Am J Obstet Gynecol.– 2000.– N.183.– P.805-809.

109. Hypponen, E. Vitamin D for the prevention of preeclampsia? A hypothesis /

E. Hypponen // Nutrition Reviews J. – 2005. – Vol.63, N.7. – P. 225-232.

110. Imdad, A. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders / A. Imdad, A. Jabeen, Z.A.Bhutta // BMC Public Health. – 2011. – N.11, suppl 3. - S18.

111. Inversetti, A. Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease / A. Inversetti, M. Smid, M. Candiani et al. // Expert Opinion on Biological Therapy. - 2014. - Vol.14, - N.8. – P. 1161- 1173.

112. Kane, S.C. New directions in the prediction of pre-eclampsia / S.C. Kane,

F. Da Silva Costa, S.P. Brennecke // ANZJOG Australian and New Zealand Journal of Obstetrics and Gynaecology. – 2014. – Vol.54, - N.2. – P. 101–107.

113. Kane, S.C. Contemporary clinical management of the cerebral complications of preeclampsia / S.C. Kane, A. Dennis, F. da Silva Costa et al. // Obstetrics and Gynecology International. – 2013. – Vol.2013. - Article ID 985606, 10 pages.

114. Khalil, A. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk / A. Khalil, N.J. Cowans, K. Spenser et al. // Ultrasound Obstet Gynecol. – 2010. – Vol.35, - N.6. – P. 671–679.

115. Kilari, A. A novel molecular mechanistic hypothesis to validate the therapeutic effects of tribulus terrestris (Gokshur) to ameliorate pathophysiology and improve pregnancy and fetal outcome in preeclampsia / A. Kilari, M. Deshpande, S. Joshi // Gynecol Obstet (Sunnyvale). – 2014. – Vol.4 – N.1. – P. 1-7.

116. Kim, Shin-Young. Maternal plasma and amniotic fluid SFLT-1 and PLGF levels at the time of mid- trimester amniocentesis in women who subsequently develop preeclampsia / Shin-Young Kim, Hyun-Mee Ryu, Jag-Hyng Jang // Am J Obstet Gynecol – 2006. – Vol.195, N.6, suppl 130.

117. Kliman, H.J. Placental protein13 and decidual zones of necrosis: immunologic diversion that may by linked to pre-tclampsia / H.J. Kliman, M. Sammar,

Grimpel et al. // Reproductive Science. – 2011. –N.0. – P. 1 – 15.

118. Koga, K. Elevated serum soluble vascular endothelial growth factor receptor 1

(sVEGFR-1) levels in women with preeclampsia / K. Koga, Y. Osuga, O. Yoshino et al. // J Clin Endocrinol Metab. – 2003. – Vol.88, N.5. – P. 2348-2351.

119. Kopcow, H. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia / H. Kopcow, S.Karumanchi // J Reprod Immunol.–2007.–N.7–P.23- 29.

120. Kronborg, C.S. Longitudinal measurement of cytokines in preclamptic and normotensive pregnancies / C.S.Kronborg, J.G. Jedsted, E. Wittinghus et al. // Acta Obstet Gynecol Scand. – 2011. – Vol.90, N.7. – P. 791 – 796.

121. Lai, J. Maternal serum placental growth factor, pregnancy-associated plasma protein-A and free β-Human chorionic conadotrophin at 30-33 weeks in the prediction of pre-eclampsia / J. Lai, A. Pinas, L.C.Y. Poon et al. // Fetal Diagn Ther. -2013. - Vol.33, - N.3. – P. 164-172.

122. Lapaire, O. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application / O. Lapaire, A. Shennan, H.Stepan // Europ J Obstet Gynecol. – 2010.

– N.151. – P. 122-129.

123. Leslie, K. Early prediction and prevention of pre-eclampsia // K. Leslie,

B. Thilaganathan, A. Papageorghiou // Best Pract Res Clin Obstet Gynaecol. – 2011. – Vol. 25, N.3. – P. 343 – 354.

124. Leung, K.Y. First-trimester ultrasound volumetry / K.Y. Leung, T. Ma, B. Lau,

G. Minchen // Expert Rev Obstet Gynecol. – 2012. – Vol.7, N.4. – P. 379 – 386.

125. Levine, R.J. Circulating angiogenic factors and the risk of preeclampsia /

Levine, S.E. Maynard, C. Qian et al. // N Engl J Med. – 2004. – N.350. – P. 672-683.

126. Lim, J.H. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors / J.H. Lim, S.Y. Kim, S.Y. Park et al. // Obstet Gynecol. - 2008. – Vol.111, N.6. – P. 1403-1409.

127. Lindheimer, M.D. The roll-over test / M.D. Lindheimer, J.M. Roberts,

F.G. Cunningham // Sao Paulo Med. J. – 1997. – Vol. 115, N.5. – P. 1533-1536.

128. Liu, X.L. Anti-β2 glycoprotein I antibodies and pregnancy outcome in

antiphospholipid syndrome / X.L. Liu, J. Xiao, F. Zhu. // Acta Obstet Gynecol Scand. – 2013. – Vol.92, N.2. – P. 234-237.

129. Lopez-Mendez, M.A. Doppler ultrasound evaluation in preeclampsia /

M.A. Lopez-Mendez, V. Martinez-Gaytan, R. Cortes-Flores et al. // BMC Research Note. – 2013, 6:477.

130. Machado, S. Diagnosis, pathophysiology and management of pre-eclampsia: a review / S. Machado, M. Neves, L. Freitas, M. Campos // Port J Nephrol Hypert. – 2013. – Vol. 27(3). – P. 153-161.

131. MacKay, A. Pregnancy-related mortality from preeclampsia and eclampsia /

A. MacKay, C. Berg, H.Atrash // Obstet Gynecol. – 2001. – Vol.97, N.4. – P. 533- 538.

132. Maynard, S. Preeclampsia and angiogenic imbalance / S.Maynard, F.H.Epstein, S.A.Karumanchi // Annu Rev Med. – 2008. – N.59 – P. 61-78.

133. Mazar, R.M. Metabolic score as a novel approach to assessng preeclampsia risk /

R.M. Mazar, S.K.Srinivas, M.D. Sammel et al. // Am J Obstet Gynecol. – 2007. - Vol.197, N4. – P. 411e1-e5.

134. Meiri, H. First trimester PP13 as a marker for prediction of pre-eclampsia /

H. Meiri, N. Chefetz, M. Sammar et al. // Biomarkers, CLI. - 2006

135. Melchiorre, K. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia / K. Melchiorre, B. Wormald, K. Leslie et al. // Ultrasound Obstet Gynecol. – 2008. – Vol.32, - N.2. – P. 133–137.

136. Mello, G. Thrombophilia is significantly associated with severe preeclampsia results of a large-scale, case-controlled study / G. Mello, E. Parretti, L. Marozio et al. // Hypertension. – 2005. – Vol. 46. – P. 1270-1274.

137. Metcalfe, A. Prediction of obstetrical risk using maternal serum markers and clinical risk factors / A. Metcalfe, S. Langlois, J. MacFarlane et al. // Prenatal Diagnosis. – 2014. – Vol.34, - N.2. – P. 172–179.

138. Metz, T.D. Preeclampsia in high risk women is characterized by risk group- specific abnormalities in serum biomarkers / T.D. Metz, A.A. Allshouse,

A.G. Euser, K.D. Heyborne // American Journal of Obstetrics & Gynecology. –

2014. - Vol. 211, - N.5. – P. 512.e1–512.e6.

139. Minakami, H. Gestational thrombocytopenia / H. Minakami, I. Sato // Lancet. – 2000. – N.356. – P. 1354-1355.

140. Molvarec, A. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia / A. Molvarec, A. Szarka,

S. Walentin et al. // Hypertension Research. – 2010. – Vol.33. – P. 892-898.

141. Moore Simas, T.A. Angiogenic factors for the prediction of preeclampsia in high- risk women / T.A. Moore Simas, S.L. Crawford, M.J. Solitro et al. // Am J Obstet Gynecol. – 2007. – N.197. – P. 244-248.

142. Morlin, B. Nitric oxide induces endometrial secretion at implantation time /

B. Morlin, E. Andersson, B.Bystrom // Acta Obstet Gynecol Scand. – 2005. – N.84. – P. 1029-1034.

143. Murphy, S.R. Role of endothelin in mediating soluble fms-like tyrosine kinase 1- induced hypertension in pregnant rats / S.R. Murphy, B. LaMarca, K. Cockrell,

J. Granger // Hypertension. – 2010. – N.55 – P. 394-398.

144. Myers, J.E. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study /

J.E. Myers, L.C. Kenny, L.M.E. McCowan et al. // BJOG. – 2013. – Vol.120, - N.10. – P. 1215–1223.

145. Napolitano, R. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices / R. Napolitano,

R. Rajakulasingam, A. Memmo et al. // Ultrasound Obstet Gynecol. - 2011. – Vol. 37, - N.5. – P. 534–537.

146. National Institute for Health and Clinical Excellence. NICE clinical guideline 107.

Hypertension in pregnancy. The management of hypertensive disorders during pregnancy / NICE, - 2010.

147. Nicolaides, K.H. A novel approach to first-trimester screening for early pre- eclampsia combining serum PP-13 and Doppler ultrasound / K.H. Nicolaides,

R. Bindra, O.M. Turan et al. // Ultrasound in Obstet Gynecol. – 2006. – Vol.27,

N.1. – P. 13-17.

148. North, R. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort / R. North, L. McCowan, G. Dekker et al. // BMJ. – 2011. - Vol.342. - d1875.

149. Odibo, A.O. First- trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia / A.O. Odibo,

Y. Zhong, K.R. Goetzinger et al. // Placenta. – 2011. – N.32. – P. 598 – 602.

150. Odibo, A.O. Pregnancy associated-plasma protein-A (PAPP-A) and alfa- fetoprotein (AFP) associated with placental abruption / A.O. Odibo // Am J Obstet Gynecol. – 2014. – Vol.211, N.2. – P. 89-90.

151. Onwudiwe, N. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure / N.Onwudiwe, C.K. Yu,

L.C. Poon et al. // Ultrasound Obstet Gynecol. – 2008. – Vol.32, N.7. – P. 877-883.

152. Ophir, E. Newborns of pre-eclamptic women: a biochemical difference present in utero / E. Ophir, G. Dourleshter, Y. Hirsh et al. // Acta Obstet Gynecol Scand. – 2006. – Vol.85, N.10. – P. 1172-1178.

153. Papageorghiou, A.T. Predicting and preventing pre-eclampsia—where to next? /

A.T. Papageorghiou // Ultrasound Obstet Gynecol. - 2008. – Vol.31, - N.4. – P. 367–370.

154. Parra, M. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markersof oxidative stress and endothelial dysfunction

/ M. Parra, R. Rodrigo, P. Barja // Am J Obstet Gynecol. – 2005. – VOL.193, N.4.

– P. 1486-1491.

155. Parra-Cordero, M. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy / M. Parra-Cordero, R. Rodrigo, P. Barja et al. // Ultrasound Obstet Gynecol. - 2013. – Vol.41, - N.5. – P. 538–544.

156. Pattison, N.S. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? / N.S. Pattison, L.W. Chamley,

M. Birdsall et al. // Am J Obstet Gynecol. – 2000. – N.183. – P. 1008-1012.

157. Payne, B. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission / B. Payne, S. Hodgson, J.A. Hutcheon et al. // BJOG. – 2013. – Vol.120, - N.1. – P. 113–118.

158. Petri, M. Pregnancy in SLE / M. Petri // Baillieres Clin Rheumatol. – 1998. - N12. – P. 151- 155.

159. Pilalis, A. Scrining for preeclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11 – 14 weeks gestation / A. Pilalis, A.P. Souka,

P. Antsaklis et al. // Ultrasound Obstet Gynecol. – 2007. – N.29. – P. 135 – 140.

160. Pipkin, F.B. Risk factors for preeclampsia / F.B. Pipkin // N Engl J Med. - 2001. – N.344. – P. 925-926.

161. Plasencia, W. Uterine artery Doppler at 11 to 13 weeks in the prediction of pre- eclampsia / W.Plasencia, N. Maiz, L. Poon, H. Nicolaides // Ultrasound. Obstet. Gynecol. - 2008. - Vol.32. - P.138 – 146.

162. Poon, L.C. First-Trimesters maternal serum pregnancy-associated plasma protein- A and pre-eclampsia / L.C. Poon, N. Maiz, C. Valencia et al. // Ultrasaund Obstet Gynecol. – 2009. - Vol 33. - P. 23-33.

163. Poon, L.C. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks / L.C. Poon,

V. Stratieva, S. Piras et al. // Prenat Diagn. – 2010. - Vol.30. - P. 216 - 223.

164. Prajapati, S.R. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler, and mean arterial pressure (A Prospective Study of 200 Cases) / S.R. Prajapati, N. Maitra // The Journal of Obstetrics and Gynecology of India. – 2013. – Vol. 63(1). – P. 32-36.

165. Rana, S. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia / S. Rana, S.A. Karumanchi, R.J. Levine // Hypertension. – 2007. – N.50. – P. 137-142.

166. Redman, C.W. Preeclampsia: an excessive maternal inflammatory response to pregnancy / C.W. Redman, G.P. Sacks, I.L.Sargent // Am J Obstet Gynecol. – 1999. – N.180. – P. 499-506.

167. Roberge, S. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis / S. Roberge, K. H. Nicolaides, S. Demers et al.

// Ultrasound in Obstetrics & Gynecology. - 2013. – Vol.41, – N.5. – P. 491–499.

168. Roberts, J.M. The two stage model of preeclampsia: variations on the theme /

J.M. Roberts, C.A. Hubelab // Placenta. – 2009. – N.30, - P. 32-37.

169. Roberts, J.M. Vitamins C and E to prevent complications of pregnancy-associated hypertension / J.M. Roberts, L. Myatt, C.Y. Spong et al. // N Engl J Med. - 2010.

– Vol.362, N.14. – P. 1282-1291.

170. Roberts, M. Pathogenesis and genetics of pre-eclampsia / M. Roberts, D.Cooper // Lancet. – 2001. – N.357. – P. 53-56.

171. Rocha-Hernandez, J.F. Other predictive markers of pre-eclampsia / J.F. Rocha- Hernandez, C. Zerquera-Gonzalez, M.A. Santos-Pena et al. // BMJ – 2008. – N.336 – P. 1079-1080.

172. Roes, E.M. First trimester inhibin-A concentrations and later development of preeclampsia / E.M. Roes, M. Gaytant, C. Thomas et al. // Acta Obstet Gynecol Scand. – 2004. – Vol.83, N.1. – P. 117

173. Rogers, E. Folate deficiency and plasma homocysteine during increased oxidative stress / E. Rogers, B. Shan Shen Chen, E.Chan // New Engl J Med. – 2007. – N.357. – P. 421-424.

174. Rossi, A.C. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis / A.C.Rossi

// Eur J Obstet Gynecol Reprod Biol. – 2011. – Vol.158, N.1. – P. 9-16.

175. Ruano, R. Prevention of preeclampsia with low dose aspirin – a systematic review and meta-analysis of the main randomized controlled trials / R. Ruano, R. Fontes, M. // Zugaib Clinics. – 2005. – Vol.60, N.5. – P. 407-414.

176. Ruma, M. Maternal periodontal disease, systemic inflammation, and risk for preeclampsia / M. Ruma, K. Boggess, K. Moss et al. // Am J Obstet Gynecol. – 2008. – N.198. – P. 389-385.

177. Sanna, G. Central nervous system involvement in the antiphospholipid (Hughes) syndrome / G. Sanna, M.L. Bertolaccini, M.J. Guadrado et al. // Rheumatology. –

2003. – Vol.42, N.2. – P. 200-213.

178. Sawidou, M.D. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre- eclampsia / M.D. Sawidou, A.D. Hingorani, D. Tsikas et al. // Lancet. – 2003. – N.361. – P. 1511-1517.

179. Saxena, A.R. First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia / A.R. Saxena,

E.W. Seely, J.W. Rich-Edwards et al. //BMC Pregnancy and Childbirth. - 2013, 13:85.

180. Scazzoccio, E. Performanse of a first trimester screening of preeclampsif in a routine care low-risk setting / E. Scazzoccio, F. Figueras, F. Crispi et al. // Am J Obstet Gynecol. – 2013. – Vol.208, N.3. – P. 203e1 – 203e10.

181. Schisterman, E.F. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial / E.F. Schisterman, R.M. Silver, L.L. Lesher et al. // The Lancet. – 2014. – Vol.384, N.9937. – P. 29-36.

182. Schoofs, K. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction / K. Schoofs,

U. Grittner, Th. Engels et al. // Journal of Perinatal Medicine. - 2014. – Vol.42, - N.1. – P. 61–68.

183. Shaarawy, M. Plasma endothelin-1 and mean arterial pressure in the prediction of pre-eclampsia / M. Shaarawy, A. Abdel-Magid // Int J Gynaecol Obstet. – 2000. – Vol.68, N.2. – P. 105-111.

184. Sibai, B. Pre-eclampsia / B. Sibai, G. Dekker, M. Kupferminc // Lancet. - 2005. – N.365. – P. 785-799.

185. Sibai, B.M. Prevention of preeclampsia. A big disappointment / B.M. Sibai // Am J Obstet Gynecol. – 1998. – N.179. – P. 1275-1278.

186. Simchen, M.J. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome / M.J. Simchen, M. Dulitzki, G. Rofe et al. // Acta Obstet Gynecol Scand. – 2011. – Vol.90, N.12. – P. 1428 – 1433.

187. Simone, N.D. Pregnancies complicated with antiphospholipid syndrome: the

pathogenic mechanism of antiphospholipid antibodies / N.D. Simone, M.P. Luigi, D'A. Marco et al. // Annals of the New York Academy of Sciences. – 2007. - Vol.1108. – P. 505–514.

188. Skjaerven, R. Recurrence of pre-eclampsia across generations exploring fetal and maternal genetic components in a population based cohort / R. Skjaerven,

L.J. Vatten, A.J. Wilcox et al. // BMJ – 2005. – Vol.331, N.7521. – P. 877.

189. Spencer, K. First trimester maternal serum PP-13, PAPP-A and second trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia / K. Spencer,

N.J. Cowans, I. Chefetz et al. // Ultrasound in Obstet Gynecol J. – 2007. – Vol.29, N.2. – P. 128-134.

190. Spencer, K. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia / K. Spencer, N.J. Cowans, I. Chefetz et al. // Prenatal Diagnosis. – 2007. – Vol.27, N.3. – P. 258-263.

191. Spinnato, J.A. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial / J.A. Spinnato, S. Freire, E. Pinto et al. // Obstet Gynecol. – 2007.

– Vol.110, N.60. – P. 1311-1318.

192. Stevens, D.U. Cardiovascular and thrombogenic risk of decidual vasculopathy in preeclampsia / D.U. Stevens, S. Al-Nasiry, M.M. Fajta, J. Bulten // Am J Obstet Gynecol. – 2014. – Vol.210, N.6. – P. 545.e1–545.e6.

193. Syngelaki, A. Body mass indexat 11 – 13 weeks gestation and pregnancy complications / A. Syngelaki, F.E. Bredaki, E. Vaikousi et al. // Fetal Diagn Ther.

– 2011. – N.30. – P. 250 – 265.

194. Szarca, A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array / A. Szarka,

J. Rigo, L. Lazar et al. // BMC Immunol. – 2010, 11: 59.

195. Taylor, R.N. Longitudinal serum concentrations of placental growth factor evidence for abnormal placental angiogenesis in pathologic pregnancies /

R.N. Taylor, J. Grimwood, R.S. Taylor et al. // Am J Obstet Gynecol. – 2003. – N.188. – P. 177-182.

196. Teixeira, P.G. Placental growth factor (PlGF) is a surrogate marker in preeclamptic

hypertension / P.G. Teixeira, A. Cabral, S. Andrade et al. // Hypertension in pregnancy. – 2008. – Vol.27, N.1. – P. 65-73.

197. Thilaganathan, B. Early-pregnancy multiple serum markers and second-trimester uterine artery doppler in predicting preeclampsia / B. Thilaganathan, B. Wormald,

C. Zanardini et al. // Obstet Gynecol. – 2010. – N.115. – P. 1233-1238.

198. Tidwell, S.C. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia / S.C. Tidwell, H.N. Ho, W.H. Chiu et al. // Am J Obstet Gynecol. – 2001. – N.184. – P. 1267-1272.

199. Tjwa, M. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis / M. Tjwa, A. Luttun, M. Autiero et al. // Cell Tissue Res. – 2003. – N.314. – P. 5-14.

200. Tobinaga, C.M. Angiogenetic factors and uterine Doppler velocimetry in early- and late-oncet preeclampsia / C.M. Tobinaga, M.R. Torloni, B.Y. Gueuvoghlanian-Silva et al. // AOGS. – 2014. – Vol. 93, - N.5. – P. 469-476.

201. Tranquilli, A.L. Placental expression of nitric oxide synthase during HELLP syndrome / A.L. Tranquilli, S.R. Giannubilo, E. Tedeschi et al. // Acta Obstet Gynecol Scand. – 2005. – N.84. – P. 849-853.

202. Tranquilli, A.L. Preeclampsia: no longer solely a pragnansy disease /

A.L. Tranquilli, B. Landi, S.R. Giannubilo, B. Sibai // Pregnancy Hypertens. – 2012. - Vol.2, N4. – P. 350 – 357.

203. Trivedi, N.A. A meta-analysis of low-dose aspirin for prevention of preeclampsia /

N.A. Trivedi // J Postgrad Med Year. – 2011. – Vol.57, - N.2 – P. 91-95.

204. Tyler, C.P. Brain damage in preterm newborns and maternal medication: the Elgan Study / C.P. Tyler, N. Paneth, E.N. Allred et al. // Am J Obstet Gynecol. – 2012. – N.207. – P. 192e1 – 192e9.

205. Vatten, L.J. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia / L.J. Vatten, A. Eskild, T. Nilsen et al. // Am J Obstet Gynecol. – 2007. – Vol.196, N.3. – P. 239e1-239e6.

206. Venkat-Raman, N. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome / N. Venkat-Raman, T. May Backos,

W. Tech et al. // Obstet Gynecol. – 2001. – Vol.98, N.2. – P. 235-242.

207. Verloren, S. The sFlt-1/PIGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients / S. Verloren,

I. Herraiz, O. Lapaire // Am J Obstet Gynecol. – 2012. – Vol.206, N.1. – P. 58e1– 58e8.

208. Villa, P.M. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials / P.M. Villa, E. Kajantie, K. Räikkonen et al. // BJOG. – 2013. – Vol.120, - N.1. – P. 64–74.

209. Walker, J.J. Pre-eclampsia / J.J. Walker // Lancet. – 2000. – N.356. – P. 1260- 1265.

210. Walsh, C.A. Mean arterial pressure and prediction of preeclampsia / C.A. Walsh, L.V.Baxi // BMJ – 2008. – Vol.336, N.7653. – P. 1079-1080.

211. Wang, A. Preeclampsia: the role of angiogenic factors in its pathogenesis /

A. Wang, S. Rana, S.A. Karumanchi // Physiology. – 2009. – Vol.24, N.3. – P. 147-158.

212. Wei, Shu-Qn. Maternal plasma 25-hydroxyvitamin D levels, angiogenic factors and preeclampsia / Shu-Qn Wei, F. Audibert Zong-Cheng Luo et al. // Am J Obstet Gynecol – 2013. – Vol.208, N.5. – P. 390e1 – 390e6.

213. Wen, Shi Wu. Folic acid supplementation in early second trimester and the risk of preeclampsia / Shi Wu Wen, Xi–Kuan Chen, M. Rodger et al. // Am J Obstet Gynecol. – 2008. – N.198. – P. 45e1-45e7.

214. Whitecar, P.W. Altered expression of TCR-CD3zeta induced by sera from women with preeclampsia / P.W. Whitecar, K.A. Boggess, M.J. McMahon et al. // Am J Obstet Gynecol. – 2001. – N.185. – P. 812 – 818.

215. Whitley, G.S. Trophoblast-mediated spiral artery remodelling: a role for apoptosis

/ G.S. Whitley, J.E. Cartwright // Anat. – 2009. – Vol.215, N.1. – P. 21-26.

216. WHO. Mother-Baby Pakage. Geneva, - 1994. – 85 p.

217. WHO. Reduction of maternal mortality. WHO, Geneva, - 2005. – 41 p.

218. WHO: Trends in maternal mortality: 1990 to 2013. Estimates by WHO, UNICEF,

UNFPA, The World Bank and the United Nations Population Division. WHO, - 2014. – 56 p.

219. Xu Xiong. Maternal smoking and preeclampsia / Xu Xiong, Fu-Lin Wang,

S.T. Davidge // J Reprod Med. – 2000. – N.45. – P. 727-732.

220. Yamada, H. Anti-β2 glycoprotein-I antibody increases the risk of pregnancy- induced hypertension: a case-controlled study / H. Yamada, T. Atsumi,

O. Amengual et al. // Journal of Reproductive Immunology. - 2010. – Vol.84, - N.1. - P. 95–99.

221. Yaron, Y. Decreased first trimester PAPP-A is a predictor of adverse outcome /

Y. Yaron, S. Heifetz, Y. Ochshorn et al. // Prenat Diagnos. – 2002. – Vol.22 – P.778–82.

222. Yu, J. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia / J. Yu, C.Z. Shixia, Y. Wu,

T. Duan et al. // Ultrasound Obstet Gynecol. – 2011. – Vol.37. – P. 528–533.

223. Yulug, E. Apoptotic and morphological features of the umbilical artery endothelium in mild and severe pre-eclampsia / E. Yulug, E. Yenilmez, M. Unsal et al. // Acta Obstet Gynecol Scand. – 2006. – Vol.85, N.9. – P. 1038-1045.